Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

TRC 4186

X
Drug Profile

TRC 4186

Alternative Names: TRC-4186; TX-41XX

Latest Information Update: 15 Apr 2021

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Torrent Pharmaceuticals
  • Class Heart failure therapies; Hydrazines; Pyridinium compounds; Small molecules; Sulfones; Thiophenes
  • Mechanism of Action Advanced glycosylation end product inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Diabetic complications; Heart failure

Most Recent Events

  • 15 Apr 2021 TRC 4186 is still in phase II trials for Diabetic complications and Heart failure
  • 15 Apr 2021 Torrent Pharmaceuticals plans a phase III trial for Heart failure (Adjunctive treatment) in 2020
  • 23 Feb 2018 TRC 4186 is still in phase II trials for Diabetic complications and Heart failure (Torrent Pharma pipeline, February 2018)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top